Feasibility of pedometers for adults with schizophrenia: pilot study


  • Conflict of interest: The authors do not have any interests that might be interpreted as influencing the research.

I. Kane, Department of Nursing, University of Pittsburgh, 415 Victoria Building, 3500 Victoria Street, Pittsburgh, PA 15261, USA, E-mail: irk1@pitt.edu


Accessible summary

  • • The use of the pedometer to monitor walking as an adjunctive intervention to antipsychotic medications for individuals with schizophrenia may be feasible.
  • • Automatic devices or technological tools such as pedometers can provide the most reliable and consistent data on physical activity in this population.
  • • Exercise fitness and body appearance were the primary motives for subject in this study.


The purpose of this prospective and observational design study was to assess the feasibility of using a pedometer and step log to explore level of physical activity (PA) and to assess motivation to be physically active in adults with schizophrenia. Descriptive statistics were used to analyse data of 7 male and 5 female subjects. Pedometer data indicated that subjects walked an average of 4731.03 (±3318.19) steps and 5002.58 (±3041.03) during the first week and second week of the study, respectively. A minimum 30-min walk was recorded on an average of 3.67 (±1.82) days (week one) and 4.5 (±1.88) days (week two). Step logs, inconsistently maintained by subjects, were not able to be analysed. Examination of the Motives for Physical Activity Measure-Revised (MPAM-R) at baseline indicates that exercise fitness and body appearance were subjects' primary motives for PA participation. Study findings indicate that it is feasible to use a pedometer to monitor the level of PA. However, maintenance of a concurrent step log requires further consideration to determine realistic outcomes. Extrinsically focused motivations for PA in this study sample may predict low PA adherence.